TOG CEO, Torn Pracharktam, has announced the company’s financial results for the second quarter of 2023. The company's revenue from sales of goods and services totaled 662 million Baht, constituting a decrease of 3% from the same period last year, with a net profit of 117 million Baht, representing a 7% increase from the same period of the previous year, The main reason for the increase in net profit was from the increase in sales revenue and the decrease in cost of sales and services mentioned above.
Significant developments have taken place over the past few months on an investment project at TOG’s subsidiary, Thai Optical Company Limited. Site construction and preparation for the installation of high-tech machinery and equipment have been underway and are progressing smoothly. The investment is aimed at building a state-of-the-art automated Rx production line, which will not only enhance business growth, but also contribute towards sustainability initiatives.
TOG is proud to announce that the production line management systems meet international standard requirements and industry best practice guidelines, complying with the international standard for medical device manufacturing quality system, ISO13485, and the environmental standard, ISO14001. Furthermore, the project includes the installation of a Solar PV Rooftop, utilizing renewable energy, which aligns with TOG’s commitment to minimizing impact from GHG emissions.
TOG is currently working on integrating digital technology systems and implementing thorough test runs, to finalize a sophisticated and responsive automated Rx production line. The project remains on schedule, and will be ready to initiate on time, in order to serve continued business growth.